{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:35:21Z","timestamp":1792931721338,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","award":["M0725"],"award-info":[{"award-number":["M0725"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2022-YGJC-36"],"award-info":[{"award-number":["2022-YGJC-36"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MS-09"],"award-info":[{"award-number":["2023-MS-09"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.redox.2026.104433","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:09:04Z","timestamp":1791475744000},"page":"104433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Androgen receptor-regulated ZNF419 modulates ferroptosis sensitivity via the ZDHHC20\u2013GPX4 pathway in prostate cancer"],"prefix":"10.1016","volume":"97","author":[{"given":"Yuanxiang","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6737-597X","authenticated-orcid":false,"given":"Jingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2493-9938","authenticated-orcid":false,"given":"Tong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6784-9855","authenticated-orcid":false,"given":"Guiyang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104433_bib1","first-page":"10","volume":"Ca 75","author":"Siegel","year":"2025","journal-title":"Cancer statistics"},{"key":"10.1016\/j.redox.2026.104433_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15204969","article-title":"Androgen receptor signaling in prostate cancer genomic subtypes","volume":"15","author":"Hussein","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2026.104433_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/cancers16030523","article-title":"Molecular mechanisms of prostate cancer development in the precision medicine era: a comprehensive review","volume":"16","author":"Maekawa","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2026.104433_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2026.104433_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41467-024-45489-4","article-title":"Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2026.104433_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15205047","article-title":"Castration-resistant prostate cancer: from uncovered resistance mechanisms to current treatments","volume":"15","author":"Le","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2026.104433_bib7","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2026.104433_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/1061186X.2015.1086360","article-title":"Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer","volume":"24","author":"Pritchard","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.redox.2026.104433_bib9","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-05-4000","article-title":"Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer","volume":"66","author":"Stanbrough","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104433_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.15252\/emmm.201303701","article-title":"Targeting the adaptive molecular landscape of castration-resistant prostate cancer","volume":"7","author":"Wyatt","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2026.104433_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104433_bib12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1535-7163.MCT-13-0027","article-title":"NF-\u03baB2\/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants","volume":"12","author":"Nadiminty","year":"2013","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.redox.2026.104433_bib13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2026.104433_bib14","first-page":"884","article-title":"Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer, Cancer Treat","volume":"41","author":"Buttigliero","year":"2015","journal-title":"Rev."},{"key":"10.1016\/j.redox.2026.104433_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"AFFIRM investigators, increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2026.104433_bib16","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1200\/JCO.22.00193","article-title":"Improved survival with enzalutamide in patients with metastatic hormone-sensitive prostate cancer","volume":"40","author":"Armstrong","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2026.104433_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","article-title":"Resistance to second-generation androgen receptor antagonists in prostate cancer","volume":"18","author":"Schmidt","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.redox.2026.104433_bib18","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"key":"10.1016\/j.redox.2026.104433_bib19","article-title":"Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells","volume":"70","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.redox.2026.104433_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41419-025-07809-4","article-title":"SLC7A11 upregulation via AR and NEDD4L ubiquitination contributes to ferroptosis inhibition and enzalutamide resistance in castration-resistant prostate cancer","volume":"16","author":"Tang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104433_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-025-02170-6","article-title":"Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer","volume":"10","author":"Ma","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104433_bib22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104433_bib23","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","article-title":"Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104433_bib24","article-title":"Gene expression profiling following androgen receptor degradation in prostate cancer cells","author":"Bae","year":"2023","journal-title":"Gene Expression Omnibus"},{"key":"10.1016\/j.redox.2026.104433_bib25","article-title":"RNA-seq analysis of prostate cancer cells under erastin exposure","author":"Zhou","year":"2023","journal-title":"Gene Expression Omnibus (GEO)"},{"key":"10.1016\/j.redox.2026.104433_bib26","article-title":"RNA-seq analysis of YAP1 downstream targets and extracellular vesicle-mediated enzalutamide resistance in prostate cancer cells","author":"Lin","year":"2024","journal-title":"Gene Expression Omnibus (GEO)"},{"key":"10.1016\/j.redox.2026.104433_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111906","article-title":"IL-6\/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3","volume":"134","author":"Shen","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.redox.2026.104433_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.10.426","article-title":"Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer","volume":"129","author":"Shin","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2026.104433_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41420-022-01169-0","article-title":"Corosolic acid sensitizes ferroptosis by upregulating HERPUD1 in liver cancer cells","volume":"8","author":"Peng","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.redox.2026.104433_bib30","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.18632\/aging.205903","article-title":"Tsc22d3 promotes morphine tolerance in mice through the GPX4 ferroptosis pathway","volume":"16","author":"Chen","year":"2024","journal-title":"Aging"},{"key":"10.1016\/j.redox.2026.104433_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","article-title":"ATF3 promotes erastin-induced ferroptosis by suppressing system Xc","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2026.104433_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.redox.2026.104433_bib33","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-12-2350","article-title":"FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells","volume":"73","author":"Sahu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104433_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature21683","article-title":"KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks","volume":"543","author":"Imbeault","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104433_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","article-title":"Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2026.104433_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0031-6997(24)01468-6","article-title":"Multiple actions of steroid hormones--a focus on rapid, nongenomic effects","volume":"52","author":"Falkenstein","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.redox.2026.104433_bib37","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1038\/sj.onc.1203032","article-title":"Rapid signalling by androgen receptor in prostate cancer cells","volume":"18","author":"Peterziel","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2026.104433_bib38","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726004325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726004325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:19:24Z","timestamp":1792930764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726004325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S2213231726004325"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104433","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor-regulated ZNF419 modulates ferroptosis sensitivity via the ZDHHC20\u2013GPX4 pathway in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104433"}}